185 related articles for article (PubMed ID: 38376657)
1. Pharmacokinetics of Dasatinib in Rats: a Potential Food-Drug Interaction with Naringenin.
Raish M; Ahmad A; Karim BA; Jardan YAB; Ahad A; Iqbal M; Alkharfy KM; Al-Jenoobi FI; Mohammed OM
Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):239-247. PubMed ID: 38376657
[TBL] [Abstract][Full Text] [Related]
2. Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.
Raish M; Ahmad A; Shahid M; Jardan YAB; Ahad A; Kalam MA; Ansari MA; Iqbal M; Ali N; Alkharfy KM; Al-Jenoobi FI
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838589
[TBL] [Abstract][Full Text] [Related]
3. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
Raish M; Ahmad A; Ansari MA; Alkharfy KM; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
[TBL] [Abstract][Full Text] [Related]
4. Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats.
Shahid M; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N; Al-Jenoobi FI
Saudi Pharm J; 2023 Nov; 31(11):101819. PubMed ID: 37860687
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats.
Pingili R; Vemulapalli S; Mullapudi SS; Nuthakki S; Pendyala S; Kilaru N
Drug Dev Ind Pharm; 2016; 42(7):1110-7. PubMed ID: 26530401
[TBL] [Abstract][Full Text] [Related]
6. Effect of naringenin on the pharmacokinetics of metoprolol succinate in rats.
Pingili RB; Vemulapalli S; Dirisala VR; Mullapudi SS; Gullapalli Y; Kilaru NB
Xenobiotica; 2021 Aug; 51(8):926-932. PubMed ID: 34138683
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
Kanaze FI; Bounartzi MI; Georgarakis M; Niopas I
Eur J Clin Nutr; 2007 Apr; 61(4):472-7. PubMed ID: 17047689
[TBL] [Abstract][Full Text] [Related]
8. Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Luo X; Xue X; Li T; Zhang Y; Huang L; Cheng G
Curr Drug Metab; 2020; 21(13):1022-1030. PubMed ID: 33092505
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro.
Surya Sandeep M; Sridhar V; Puneeth Y; Ravindra Babu P; Naveen Babu K
Drug Dev Ind Pharm; 2014 Oct; 40(10):1371-7. PubMed ID: 23883365
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
12. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.
Hsiu SL; Huang TY; Hou YC; Chin DH; Chao PD
Life Sci; 2002 Feb; 70(13):1481-9. PubMed ID: 11895099
[TBL] [Abstract][Full Text] [Related]
13. Effects of naringenin on the pharmacokinetics of tofacitinib in rats.
Wang B; Shen J; Zhou Q; Meng D; He Y; Chen F; Wang S; Ji W
Pharm Biol; 2020 Dec; 58(1):225-230. PubMed ID: 32202190
[No Abstract] [Full Text] [Related]
14. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
[TBL] [Abstract][Full Text] [Related]
15. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia.
Ahmad N; Ahmad R; Ahmad FJ; Ahmad W; Alam MA; Amir M; Ali A
Saudi J Biol Sci; 2020 Jan; 27(1):500-517. PubMed ID: 31889876
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib significantly reduced in vivo exposure to cyclosporine in a rat model: The possible involvement of CYP3A induction.
Abdelgalil AA; Alam MA; Raish M; Mohammed IE; Hassan Mohammed AE; Ansari MA; Al Jenoobi FI
Pharmacol Rep; 2019 Apr; 71(2):201-205. PubMed ID: 30785057
[TBL] [Abstract][Full Text] [Related]
17. The effect of naringenin on the pharmacokinetics of ibrutinib in rat: A drug-drug interaction study.
Liu J; Liu H; Zeng Q
Biomed Chromatogr; 2019 May; 33(5):e4507. PubMed ID: 30754071
[TBL] [Abstract][Full Text] [Related]
18. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.
Bedada SK; Nearati P
Phytother Res; 2015 May; 29(5):701-6. PubMed ID: 25624269
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction study of combining imatinib with dasatinib in rats by UPLC-MS/MS.
Zhou Y; Wang S; Ding T; Wu M; Geng P; Zhang Q; Ma J
Drug Dev Ind Pharm; 2015; 41(12):1948-53. PubMed ID: 25632980
[TBL] [Abstract][Full Text] [Related]
20. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.
Zhang H; Wong CW; Coville PF; Wanwimolruk S
Drug Metabol Drug Interact; 2000; 17(1-4):351-63. PubMed ID: 11201303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
